[EN] REMDESIVIR AND REMDESIVIR ANALOGS, SOLUTIONS, AND NANOPARTICLE, LIPOSOMAL, AND MICROPARTICLE COMPOSITIONS FOR TREATING VIRAL INFECTIONS<br/>[FR] REMDÉSIVIR ET ANALOGUES DE REMDÉSIVIR, SOLUTIONS ET COMPOSITIONS DE NANOPARTICULES, DE LIPOSOMES ET DE MICROPARTICULES POUR LE TRAITEMENT D'INFECTIONS VIRALES
申请人:UNIV MICHIGAN REGENTS
公开号:WO2021202907A2
公开(公告)日:2021-10-07
The present invention relates to methods, compounds, and compositions for treating viral infections, including COVID-19 viral infections. In certain embodiments, the compositions comprise: i) a remdesivir analog, ii) remdesivir or a remdesivir analog, and a surfactant, a cyclodextrin, or a combination thereof, iii) nanoparticles comprising albumin and remdesivir or remdesivir analog, iv) liposomes comprising lipids and remdesivir or remdesivir analog; and/or v) microparticles comprising PLA and/or PLGA, and remdesivir or remdesivir analog. In certain embodiments, the compositions are aqueous (e.g., for intravenous administration). In other embodiments, the compositions are nebulized or in the form of a dry powder (e.g., for inhalation by an infected subject).